 Jordan Hoffman
Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tissue and Organ Procurement | 22 | 2026 | 341 | 6.040 |
Why?
| | Perfusion | 16 | 2025 | 249 | 5.110 |
Why?
| | Tissue Donors | 22 | 2026 | 413 | 4.030 |
Why?
| | Organ Preservation | 15 | 2026 | 125 | 3.960 |
Why?
| | Heart Transplantation | 18 | 2026 | 674 | 3.960 |
Why?
| | Organ Transplantation | 6 | 2026 | 247 | 1.460 |
Why?
| | Lung Transplantation | 6 | 2025 | 329 | 1.380 |
Why?
| | Brain Death | 4 | 2026 | 58 | 1.210 |
Why?
| | Registries | 6 | 2026 | 2392 | 1.080 |
Why?
| | Waiting Lists | 4 | 2025 | 263 | 1.020 |
Why?
| | Primary Graft Dysfunction | 2 | 2025 | 33 | 1.010 |
Why?
| | Consensus | 3 | 2024 | 475 | 0.940 |
Why?
| | Lichens | 2 | 2023 | 16 | 0.940 |
Why?
| | Intracranial Pressure | 1 | 2025 | 65 | 0.880 |
Why?
| | Organ Preservation Solutions | 1 | 2023 | 46 | 0.800 |
Why?
| | Tissue and Organ Harvesting | 1 | 2024 | 78 | 0.790 |
Why?
| | Transplant Recipients | 1 | 2025 | 180 | 0.790 |
Why?
| | Genome, Mitochondrial | 1 | 2023 | 29 | 0.750 |
Why?
| | Cerebrovascular Circulation | 1 | 2025 | 289 | 0.750 |
Why?
| | Extracorporeal Membrane Oxygenation | 5 | 2026 | 387 | 0.730 |
Why?
| | Terminology as Topic | 1 | 2024 | 255 | 0.720 |
Why?
| | Cold Ischemia | 1 | 2021 | 40 | 0.660 |
Why?
| | Graft Rejection | 4 | 2026 | 512 | 0.660 |
Why?
| | Cardiac Surgical Procedures | 3 | 2024 | 609 | 0.620 |
Why?
| | Blood Pressure | 2 | 2025 | 1766 | 0.590 |
Why?
| | Vascular Stiffness | 1 | 2023 | 485 | 0.560 |
Why?
| | Heart Failure | 5 | 2025 | 2324 | 0.560 |
Why?
| | Graft Survival | 7 | 2026 | 510 | 0.530 |
Why?
| | Death | 4 | 2025 | 131 | 0.470 |
Why?
| | Humans | 52 | 2026 | 144667 | 0.460 |
Why?
| | Thoracic Injuries | 1 | 2016 | 71 | 0.440 |
Why?
| | ABO Blood-Group System | 2 | 2025 | 55 | 0.440 |
Why?
| | Ventricular Dysfunction, Right | 3 | 2022 | 248 | 0.420 |
Why?
| | Follow-Up Studies | 9 | 2026 | 5414 | 0.400 |
Why?
| | Retrospective Studies | 18 | 2026 | 17149 | 0.390 |
Why?
| | Adult | 20 | 2026 | 40489 | 0.390 |
Why?
| | Aorta, Thoracic | 1 | 2016 | 285 | 0.380 |
Why?
| | Wounds, Nonpenetrating | 1 | 2016 | 321 | 0.360 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2016 | 337 | 0.360 |
Why?
| | Hypertension, Pulmonary | 1 | 2023 | 1948 | 0.360 |
Why?
| | Stents | 1 | 2016 | 557 | 0.340 |
Why?
| | Heart Ventricles | 4 | 2021 | 751 | 0.340 |
Why?
| | Ventricular Function, Right | 3 | 2023 | 296 | 0.340 |
Why?
| | Surgeons | 3 | 2025 | 341 | 0.320 |
Why?
| | Male | 21 | 2026 | 72431 | 0.290 |
Why?
| | Prognosis | 5 | 2026 | 4312 | 0.280 |
Why?
| | Middle Aged | 18 | 2026 | 35971 | 0.270 |
Why?
| | Rectum | 1 | 2009 | 183 | 0.260 |
Why?
| | Female | 20 | 2026 | 78304 | 0.260 |
Why?
| | Rectal Neoplasms | 1 | 2009 | 158 | 0.260 |
Why?
| | Time Factors | 5 | 2026 | 7140 | 0.260 |
Why?
| | Carcinoma | 1 | 2009 | 224 | 0.260 |
Why?
| | United States | 13 | 2026 | 16018 | 0.250 |
Why?
| | Survival Analysis | 3 | 2021 | 1370 | 0.240 |
Why?
| | Survival Rate | 6 | 2026 | 2089 | 0.240 |
Why?
| | Blood Group Incompatibility | 1 | 2025 | 19 | 0.230 |
Why?
| | Warm Ischemia | 1 | 2025 | 18 | 0.230 |
Why?
| | Heart-Assist Devices | 2 | 2021 | 568 | 0.220 |
Why?
| | Hypothermia | 1 | 2025 | 52 | 0.220 |
Why?
| | Resource Allocation | 1 | 2025 | 52 | 0.210 |
Why?
| | Raffinose | 1 | 2023 | 29 | 0.210 |
Why?
| | Allopurinol | 1 | 2023 | 70 | 0.200 |
Why?
| | Intraoperative Complications | 1 | 2025 | 157 | 0.200 |
Why?
| | Coronary Artery Bypass | 1 | 2026 | 267 | 0.200 |
Why?
| | Donor Selection | 1 | 2024 | 79 | 0.200 |
Why?
| | Synteny | 1 | 2023 | 14 | 0.190 |
Why?
| | Costs and Cost Analysis | 1 | 2024 | 221 | 0.190 |
Why?
| | Allografts | 1 | 2023 | 150 | 0.190 |
Why?
| | Shock | 1 | 2024 | 108 | 0.190 |
Why?
| | Benzofurans | 1 | 2022 | 26 | 0.180 |
Why?
| | Cardiac Catheterization | 2 | 2023 | 557 | 0.180 |
Why?
| | Ascomycota | 1 | 2022 | 28 | 0.180 |
Why?
| | Coronary Artery Disease | 2 | 2026 | 743 | 0.180 |
Why?
| | Heart-Lung Transplantation | 1 | 2022 | 13 | 0.180 |
Why?
| | Adenosine | 1 | 2023 | 255 | 0.180 |
Why?
| | Glutathione | 1 | 2023 | 366 | 0.180 |
Why?
| | Fellowships and Scholarships | 1 | 2026 | 355 | 0.170 |
Why?
| | Prostatic Neoplasms | 1 | 2009 | 978 | 0.170 |
Why?
| | Heart Valve Prosthesis | 1 | 2023 | 129 | 0.170 |
Why?
| | Hepatitis C | 1 | 2023 | 254 | 0.160 |
Why?
| | Pulmonary Artery | 2 | 2023 | 1124 | 0.160 |
Why?
| | Cardiac Output | 1 | 2020 | 179 | 0.160 |
Why?
| | Human Embryonic Stem Cells | 1 | 2019 | 24 | 0.150 |
Why?
| | DNA (Cytosine-5-)-Methyltransferases | 1 | 2019 | 36 | 0.150 |
Why?
| | Myocardial Contraction | 1 | 2020 | 288 | 0.150 |
Why?
| | CpG Islands | 1 | 2019 | 161 | 0.140 |
Why?
| | Biological Evolution | 1 | 2023 | 488 | 0.140 |
Why?
| | Treatment Outcome | 4 | 2025 | 11735 | 0.140 |
Why?
| | Glucose | 1 | 2023 | 1033 | 0.140 |
Why?
| | Phylogeny | 1 | 2023 | 1024 | 0.140 |
Why?
| | Anastomosis, Surgical | 1 | 2019 | 161 | 0.140 |
Why?
| | Respiratory Insufficiency | 1 | 2022 | 324 | 0.140 |
Why?
| | Vena Cava, Inferior | 1 | 2019 | 81 | 0.140 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2022 | 370 | 0.140 |
Why?
| | Heart Atria | 1 | 2019 | 141 | 0.140 |
Why?
| | Predictive Value of Tests | 1 | 2023 | 2117 | 0.130 |
Why?
| | Liver Transplantation | 1 | 2025 | 826 | 0.130 |
Why?
| | Spontaneous Perforation | 1 | 2016 | 2 | 0.120 |
Why?
| | Aortography | 1 | 2016 | 52 | 0.120 |
Why?
| | Vena Cava Filters | 1 | 2016 | 64 | 0.110 |
Why?
| | Kidney Transplantation | 1 | 2022 | 709 | 0.110 |
Why?
| | Liver Neoplasms | 1 | 2022 | 777 | 0.110 |
Why?
| | Promoter Regions, Genetic | 1 | 2019 | 1246 | 0.110 |
Why?
| | DNA Methylation | 1 | 2019 | 664 | 0.100 |
Why?
| | Heart | 3 | 2023 | 626 | 0.100 |
Why?
| | Blood Vessel Prosthesis Implantation | 1 | 2016 | 228 | 0.100 |
Why?
| | Adolescent | 2 | 2023 | 22409 | 0.090 |
Why?
| | Acute Coronary Syndrome | 1 | 2016 | 295 | 0.090 |
Why?
| | Trauma Centers | 1 | 2016 | 466 | 0.090 |
Why?
| | Insulin | 1 | 2023 | 2502 | 0.090 |
Why?
| | Aged | 4 | 2026 | 25955 | 0.090 |
Why?
| | Tomography, X-Ray Computed | 2 | 2016 | 2754 | 0.090 |
Why?
| | Hemostatic Techniques | 1 | 2012 | 52 | 0.090 |
Why?
| | Blood Loss, Surgical | 1 | 2012 | 110 | 0.090 |
Why?
| | Risk Assessment | 2 | 2023 | 3729 | 0.080 |
Why?
| | Hospital Mortality | 1 | 2016 | 1033 | 0.080 |
Why?
| | Magnetic Resonance Imaging | 1 | 2023 | 3888 | 0.080 |
Why?
| | Cardiovascular Diseases | 1 | 2023 | 2172 | 0.080 |
Why?
| | Endovascular Procedures | 1 | 2016 | 385 | 0.080 |
Why?
| | Risk Factors | 4 | 2026 | 10796 | 0.080 |
Why?
| | Resuscitation | 1 | 2012 | 310 | 0.070 |
Why?
| | Pelvic Exenteration | 1 | 2009 | 12 | 0.070 |
Why?
| | Exercise | 1 | 2020 | 2183 | 0.070 |
Why?
| | Neoplasm Invasiveness | 1 | 2009 | 503 | 0.060 |
Why?
| | Stroke Volume | 2 | 2020 | 650 | 0.060 |
Why?
| | Hemorrhage | 1 | 2012 | 813 | 0.060 |
Why?
| | Colonoscopy | 1 | 2009 | 260 | 0.060 |
Why?
| | Biopsy | 1 | 2009 | 1079 | 0.060 |
Why?
| | Cohort Studies | 1 | 2016 | 5957 | 0.050 |
Why?
| | Europe | 1 | 2026 | 419 | 0.050 |
Why?
| | Abdomen | 1 | 2025 | 141 | 0.050 |
Why?
| | Young Adult | 1 | 2021 | 14122 | 0.050 |
Why?
| | United Kingdom | 1 | 2025 | 337 | 0.050 |
Why?
| | Cause of Death | 1 | 2026 | 464 | 0.050 |
Why?
| | Polyketide Synthases | 1 | 2022 | 7 | 0.050 |
Why?
| | Thoracic Surgical Procedures | 1 | 2024 | 95 | 0.050 |
Why?
| | Travel | 1 | 2023 | 136 | 0.050 |
Why?
| | Hepacivirus | 1 | 2023 | 243 | 0.040 |
Why?
| | Postoperative Complications | 2 | 2025 | 2950 | 0.040 |
Why?
| | Shock, Cardiogenic | 1 | 2022 | 64 | 0.040 |
Why?
| | Multigene Family | 1 | 2022 | 210 | 0.040 |
Why?
| | Coronary Angiography | 1 | 2023 | 324 | 0.040 |
Why?
| | Child | 1 | 2021 | 22600 | 0.040 |
Why?
| | Drainage | 1 | 2022 | 184 | 0.040 |
Why?
| | Chromatography, Liquid | 1 | 2022 | 444 | 0.040 |
Why?
| | Sex Factors | 1 | 2026 | 2104 | 0.040 |
Why?
| | Seizures | 1 | 2023 | 477 | 0.040 |
Why?
| | Methylation | 1 | 2019 | 241 | 0.040 |
Why?
| | Echocardiography, Transesophageal | 1 | 2019 | 132 | 0.030 |
Why?
| | Constriction, Pathologic | 1 | 2019 | 249 | 0.030 |
Why?
| | Quality of Health Care | 1 | 2023 | 692 | 0.030 |
Why?
| | Critical Care | 1 | 2024 | 695 | 0.030 |
Why?
| | Exercise Test | 1 | 2020 | 626 | 0.030 |
Why?
| | Practice Guidelines as Topic | 1 | 2025 | 1569 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2024 | 1742 | 0.030 |
Why?
| | Lysine | 1 | 2019 | 271 | 0.030 |
Why?
| | Electrocardiography | 1 | 2020 | 664 | 0.030 |
Why?
| | Cardiopulmonary Bypass | 1 | 2019 | 217 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2023 | 944 | 0.030 |
Why?
| | Activities of Daily Living | 1 | 2020 | 441 | 0.030 |
Why?
| | Base Sequence | 1 | 2019 | 2177 | 0.030 |
Why?
| | Internship and Residency | 1 | 2026 | 1262 | 0.030 |
Why?
| | Histones | 1 | 2019 | 663 | 0.030 |
Why?
| | Cell Line | 1 | 2019 | 2821 | 0.030 |
Why?
| | Protein Binding | 1 | 2019 | 2243 | 0.020 |
Why?
| | Liver | 1 | 2022 | 1889 | 0.020 |
Why?
| | Plasma Substitutes | 1 | 2012 | 5 | 0.020 |
Why?
| | Hydroxyethyl Starch Derivatives | 1 | 2012 | 9 | 0.020 |
Why?
| | Isotonic Solutions | 1 | 2012 | 42 | 0.020 |
Why?
| | Pandemics | 1 | 2021 | 1700 | 0.020 |
Why?
| | Saline Solution, Hypertonic | 1 | 2012 | 43 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2024 | 6041 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2019 | 2037 | 0.020 |
Why?
| | Infant | 1 | 2025 | 10023 | 0.020 |
Why?
| | Fluid Therapy | 1 | 2012 | 148 | 0.020 |
Why?
| | Plasma | 1 | 2012 | 223 | 0.020 |
Why?
| | Child, Preschool | 1 | 2025 | 11790 | 0.020 |
Why?
| | Erythrocyte Transfusion | 1 | 2012 | 226 | 0.020 |
Why?
| | Linear Models | 1 | 2012 | 845 | 0.020 |
Why?
| | Mutation | 1 | 2019 | 4081 | 0.020 |
Why?
| | Hemodynamics | 1 | 2012 | 1113 | 0.020 |
Why?
| | Length of Stay | 1 | 2012 | 1339 | 0.020 |
Why?
| | Intensive Care Units | 1 | 2012 | 915 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2012 | 3603 | 0.010 |
Why?
|
|
Hoffman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|